536146 Targeted, Systemic Dendrimer-Drug Therapies for Age Related Macular Degeneration

Siva Pramodh Kambhampati1,2, Imran Bhuto3, Gerard Lutty3 and Rangaramanujam Kannan4,5, (1)Ophthalmology, Johns Hopkins University, Wilmer Eye Institute, Baltimore, MD, (2)Center for Nanomedicine, Johns Hopkins University, Wilmer Eye Institute, Baltimore, (3)Ophthalmology, Johns Hopkins University, Wilmer Eye Institute, Baltimore, (4)Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, (5)Center for Nanomedicine, Johns Hopkins University, Wilmer Eye Institute, Baltimore, MD
See more of this Session: Biomaterials for Drug Delivery
See more of this Group/Topical: Materials Engineering and Sciences Division